Review



ang 1 7 receptor  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress ang 1 7 receptor
    Ang 1 7 Receptor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ang 1 7 receptor/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    ang 1 7 receptor - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    MedChemExpress ang 1 7 receptor
    Ang 1 7 Receptor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ang 1 7 receptor/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    ang 1 7 receptor - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    94
    Alomone Labs rabbit polyclonal anti ang
    Rabbit Polyclonal Anti Ang, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti ang/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti ang - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    Bachem mas receptor antagonist [d-ala 7 ]-ang-(1–7)
    Mas Receptor Antagonist [D Ala 7 ] Ang (1–7), supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mas receptor antagonist [d-ala 7 ]-ang-(1–7)/product/Bachem
    Average 90 stars, based on 1 article reviews
    mas receptor antagonist [d-ala 7 ]-ang-(1–7) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Bachem mas receptor antagonist [d-ala7]-ang-(1− 7)
    Mas Receptor Antagonist [D Ala7] Ang (1− 7), supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mas receptor antagonist [d-ala7]-ang-(1− 7)/product/Bachem
    Average 90 stars, based on 1 article reviews
    mas receptor antagonist [d-ala7]-ang-(1− 7) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    94
    Alomone Labs rabbit anti ang
    Immediately following weaning at 35 days of age, spSHR were fed a 4% sodium diet. At 49 days of age, rats were infused ICV with either aCSF (0.15 μL/h), <t>Ang-(1–7)</t> [1.0 μg in 0.15 μl aCSF/h] or Ang-(1–7) + A779 (2.5 μg in 0.15 μl aCSF/h) for the next 6 weeks. Animals were monitored and maintained on the 4% sodium diet until death. Following death, brains were removed and the numbers and severity of hemorrhages in the cortex and subcortex/striatum were analyzed as described in the Methods. Panel (A) contains survival curves for spSHR following the above treatments. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). N=9 rats for the aCSF and Ang-(1–7) groups; N=6 for the Ang-(1–7) + A779 group. *, P=0.0092, aCSF vs. Ang-(1–7) treatment; P=0.29, aCSF vs. Ang-(1–7) + A-779 treatment; P=0.07, Ang-(1–7) vs. Ang-(1–7) + A-779 treatment. Panels (B) and (D) show the numbers, and panels (C) and (E) the severity of hemorrhages in the cerebral cortex and subcortex/striatum, respectively. Bar graphs are means + SEM. *P<0.05, compared to spSHR infused with aCSF.
    Rabbit Anti Ang, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti ang/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    rabbit anti ang - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    GL Biochem a779 ang–(1–7)/mas receptor antagonist
    Immediately following weaning at 35 days of age, spSHR were fed a 4% sodium diet. At 49 days of age, rats were infused ICV with either aCSF (0.15 μL/h), <t>Ang-(1–7)</t> [1.0 μg in 0.15 μl aCSF/h] or Ang-(1–7) + A779 (2.5 μg in 0.15 μl aCSF/h) for the next 6 weeks. Animals were monitored and maintained on the 4% sodium diet until death. Following death, brains were removed and the numbers and severity of hemorrhages in the cortex and subcortex/striatum were analyzed as described in the Methods. Panel (A) contains survival curves for spSHR following the above treatments. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). N=9 rats for the aCSF and Ang-(1–7) groups; N=6 for the Ang-(1–7) + A779 group. *, P=0.0092, aCSF vs. Ang-(1–7) treatment; P=0.29, aCSF vs. Ang-(1–7) + A-779 treatment; P=0.07, Ang-(1–7) vs. Ang-(1–7) + A-779 treatment. Panels (B) and (D) show the numbers, and panels (C) and (E) the severity of hemorrhages in the cerebral cortex and subcortex/striatum, respectively. Bar graphs are means + SEM. *P<0.05, compared to spSHR infused with aCSF.
    A779 Ang–(1–7)/Mas Receptor Antagonist, supplied by GL Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a779 ang–(1–7)/mas receptor antagonist/product/GL Biochem
    Average 90 stars, based on 1 article reviews
    a779 ang–(1–7)/mas receptor antagonist - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Bioscientifica Ltd mas receptor agonist ang-(1-7)
    Immediately following weaning at 35 days of age, spSHR were fed a 4% sodium diet. At 49 days of age, rats were infused ICV with either aCSF (0.15 μL/h), <t>Ang-(1–7)</t> [1.0 μg in 0.15 μl aCSF/h] or Ang-(1–7) + A779 (2.5 μg in 0.15 μl aCSF/h) for the next 6 weeks. Animals were monitored and maintained on the 4% sodium diet until death. Following death, brains were removed and the numbers and severity of hemorrhages in the cortex and subcortex/striatum were analyzed as described in the Methods. Panel (A) contains survival curves for spSHR following the above treatments. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). N=9 rats for the aCSF and Ang-(1–7) groups; N=6 for the Ang-(1–7) + A779 group. *, P=0.0092, aCSF vs. Ang-(1–7) treatment; P=0.29, aCSF vs. Ang-(1–7) + A-779 treatment; P=0.07, Ang-(1–7) vs. Ang-(1–7) + A-779 treatment. Panels (B) and (D) show the numbers, and panels (C) and (E) the severity of hemorrhages in the cerebral cortex and subcortex/striatum, respectively. Bar graphs are means + SEM. *P<0.05, compared to spSHR infused with aCSF.
    Mas Receptor Agonist Ang (1 7), supplied by Bioscientifica Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mas receptor agonist ang-(1-7)/product/Bioscientifica Ltd
    Average 90 stars, based on 1 article reviews
    mas receptor agonist ang-(1-7) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Mimotopes mrgd receptor blocker d-pro 7 -ang-(1-7) (d-pro)
    Immediately following weaning at 35 days of age, spSHR were fed a 4% sodium diet. At 49 days of age, rats were infused ICV with either aCSF (0.15 μL/h), <t>Ang-(1–7)</t> [1.0 μg in 0.15 μl aCSF/h] or Ang-(1–7) + A779 (2.5 μg in 0.15 μl aCSF/h) for the next 6 weeks. Animals were monitored and maintained on the 4% sodium diet until death. Following death, brains were removed and the numbers and severity of hemorrhages in the cortex and subcortex/striatum were analyzed as described in the Methods. Panel (A) contains survival curves for spSHR following the above treatments. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). N=9 rats for the aCSF and Ang-(1–7) groups; N=6 for the Ang-(1–7) + A779 group. *, P=0.0092, aCSF vs. Ang-(1–7) treatment; P=0.29, aCSF vs. Ang-(1–7) + A-779 treatment; P=0.07, Ang-(1–7) vs. Ang-(1–7) + A-779 treatment. Panels (B) and (D) show the numbers, and panels (C) and (E) the severity of hemorrhages in the cerebral cortex and subcortex/striatum, respectively. Bar graphs are means + SEM. *P<0.05, compared to spSHR infused with aCSF.
    Mrgd Receptor Blocker D Pro 7 Ang (1 7) (D Pro), supplied by Mimotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mrgd receptor blocker d-pro 7 -ang-(1-7) (d-pro)/product/Mimotopes
    Average 90 stars, based on 1 article reviews
    mrgd receptor blocker d-pro 7 -ang-(1-7) (d-pro) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    94
    Alomone Labs ang
    Immediately following weaning at 35 days of age, spSHR were fed a 4% sodium diet. At 49 days of age, rats were infused ICV with either aCSF (0.15 μL/h), <t>Ang-(1–7)</t> [1.0 μg in 0.15 μl aCSF/h] or Ang-(1–7) + A779 (2.5 μg in 0.15 μl aCSF/h) for the next 6 weeks. Animals were monitored and maintained on the 4% sodium diet until death. Following death, brains were removed and the numbers and severity of hemorrhages in the cortex and subcortex/striatum were analyzed as described in the Methods. Panel (A) contains survival curves for spSHR following the above treatments. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). N=9 rats for the aCSF and Ang-(1–7) groups; N=6 for the Ang-(1–7) + A779 group. *, P=0.0092, aCSF vs. Ang-(1–7) treatment; P=0.29, aCSF vs. Ang-(1–7) + A-779 treatment; P=0.07, Ang-(1–7) vs. Ang-(1–7) + A-779 treatment. Panels (B) and (D) show the numbers, and panels (C) and (E) the severity of hemorrhages in the cerebral cortex and subcortex/striatum, respectively. Bar graphs are means + SEM. *P<0.05, compared to spSHR infused with aCSF.
    Ang, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ang/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    ang - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    Immediately following weaning at 35 days of age, spSHR were fed a 4% sodium diet. At 49 days of age, rats were infused ICV with either aCSF (0.15 μL/h), Ang-(1–7) [1.0 μg in 0.15 μl aCSF/h] or Ang-(1–7) + A779 (2.5 μg in 0.15 μl aCSF/h) for the next 6 weeks. Animals were monitored and maintained on the 4% sodium diet until death. Following death, brains were removed and the numbers and severity of hemorrhages in the cortex and subcortex/striatum were analyzed as described in the Methods. Panel (A) contains survival curves for spSHR following the above treatments. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). N=9 rats for the aCSF and Ang-(1–7) groups; N=6 for the Ang-(1–7) + A779 group. *, P=0.0092, aCSF vs. Ang-(1–7) treatment; P=0.29, aCSF vs. Ang-(1–7) + A-779 treatment; P=0.07, Ang-(1–7) vs. Ang-(1–7) + A-779 treatment. Panels (B) and (D) show the numbers, and panels (C) and (E) the severity of hemorrhages in the cerebral cortex and subcortex/striatum, respectively. Bar graphs are means + SEM. *P<0.05, compared to spSHR infused with aCSF.

    Journal: Experimental physiology

    Article Title: Centrally administered angiotensin-(1–7) increases the survival of stroke prone spontaneously hypertensive rats

    doi: 10.1113/expphysiol.2013.075242

    Figure Lengend Snippet: Immediately following weaning at 35 days of age, spSHR were fed a 4% sodium diet. At 49 days of age, rats were infused ICV with either aCSF (0.15 μL/h), Ang-(1–7) [1.0 μg in 0.15 μl aCSF/h] or Ang-(1–7) + A779 (2.5 μg in 0.15 μl aCSF/h) for the next 6 weeks. Animals were monitored and maintained on the 4% sodium diet until death. Following death, brains were removed and the numbers and severity of hemorrhages in the cortex and subcortex/striatum were analyzed as described in the Methods. Panel (A) contains survival curves for spSHR following the above treatments. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). N=9 rats for the aCSF and Ang-(1–7) groups; N=6 for the Ang-(1–7) + A779 group. *, P=0.0092, aCSF vs. Ang-(1–7) treatment; P=0.29, aCSF vs. Ang-(1–7) + A-779 treatment; P=0.07, Ang-(1–7) vs. Ang-(1–7) + A-779 treatment. Panels (B) and (D) show the numbers, and panels (C) and (E) the severity of hemorrhages in the cerebral cortex and subcortex/striatum, respectively. Bar graphs are means + SEM. *P<0.05, compared to spSHR infused with aCSF.

    Article Snippet: Rabbit anti-Ang-(1–7) Mas receptor antibody was from Alomone Labs (Jerusalem, Israel).

    Techniques:

    Panel (A), Sunflower seed eating task: Rats were fed a 4% sodium diet and infused ICV with either aCSF (0.15 μL/h) or Ang-(1–7) [1.0 μg in 0.15 μl aCSF/h] as described in the legend to Figure 1, and underwent behavioral testing via the Sunflower seed-eating task every 3 days from 56 to 102 days of age. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). Shown here is the number of shell pieces plotted against age. The timeline shows that the number of remaining shell pieces after eating 5 seeds is reduced by Ang-(1–7) treatment, as indicated by 2 way row matched ANOVA when comparing the lines. Data are means ± SEM. N=6 rats per group. Panels (B) and (C), Immobility and Rotation Frequency: Rats were subjected to the same treatments as in panel (A) and underwent testing for spontaneous locomotor activity between days 105–108 of age as described in the Methods. Bar graphs are means + SEM showing Immobility (B) and Rotation Frequency (C). N=9 rats for the aCSF treatment and 7 for Ang-(1–7). *P<0.05 compared to aCSF-treated spSHR.

    Journal: Experimental physiology

    Article Title: Centrally administered angiotensin-(1–7) increases the survival of stroke prone spontaneously hypertensive rats

    doi: 10.1113/expphysiol.2013.075242

    Figure Lengend Snippet: Panel (A), Sunflower seed eating task: Rats were fed a 4% sodium diet and infused ICV with either aCSF (0.15 μL/h) or Ang-(1–7) [1.0 μg in 0.15 μl aCSF/h] as described in the legend to Figure 1, and underwent behavioral testing via the Sunflower seed-eating task every 3 days from 56 to 102 days of age. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). Shown here is the number of shell pieces plotted against age. The timeline shows that the number of remaining shell pieces after eating 5 seeds is reduced by Ang-(1–7) treatment, as indicated by 2 way row matched ANOVA when comparing the lines. Data are means ± SEM. N=6 rats per group. Panels (B) and (C), Immobility and Rotation Frequency: Rats were subjected to the same treatments as in panel (A) and underwent testing for spontaneous locomotor activity between days 105–108 of age as described in the Methods. Bar graphs are means + SEM showing Immobility (B) and Rotation Frequency (C). N=9 rats for the aCSF treatment and 7 for Ang-(1–7). *P<0.05 compared to aCSF-treated spSHR.

    Article Snippet: Rabbit anti-Ang-(1–7) Mas receptor antibody was from Alomone Labs (Jerusalem, Israel).

    Techniques: Activity Assay

    Rats were fed a 4% sodium diet, infused ICV with either aCSF (0.15 μL/h) or Ang-(1–7) [1.0 μg in 0.15 μl aCSF/h] as described in the legend to Figure 1, and underwent measurements of MAP via tail cuff plethysmography every 2 to 5 days between days 70 and 110 of age. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). Data are means ± SEM. N=8 rats per group.

    Journal: Experimental physiology

    Article Title: Centrally administered angiotensin-(1–7) increases the survival of stroke prone spontaneously hypertensive rats

    doi: 10.1113/expphysiol.2013.075242

    Figure Lengend Snippet: Rats were fed a 4% sodium diet, infused ICV with either aCSF (0.15 μL/h) or Ang-(1–7) [1.0 μg in 0.15 μl aCSF/h] as described in the legend to Figure 1, and underwent measurements of MAP via tail cuff plethysmography every 2 to 5 days between days 70 and 110 of age. Vertical black dashed line indicates when the osmotic pumps stopped (91 days of age). Data are means ± SEM. N=8 rats per group.

    Article Snippet: Rabbit anti-Ang-(1–7) Mas receptor antibody was from Alomone Labs (Jerusalem, Israel).

    Techniques:

    (A-F) Rats were fed a 4% sodium diet, infused ICV with either aCSF (0.15 μL/h) or Ang-(1–7) [1.0 μg in 0.15 μl aCSF/h]. (A-F): At 90 days of age rats were deeply anesthetized, perfused transcardially with saline followed by 10% formalin and brains removed for immunostaining as described in the Methods. Panels A and B are representative fluorescence micrographs showing Iba-1 immunoreactivity in the striatum of aCSF and Ang-(1–7) infused rats, respectively. Panels C and D are representative fluorescence micrographs showing NeuN immunoreactivity in the striatum of aCSF and Ang-(1–7) infused rats, respectively. LV= lateral ventricle; cc = Corpus callosum. Stereological analyses of the striatum showing the estimated numbers of Iba-1 positive cells (microglia) and NeuN positive cells (neurons) are shown in panels E and F respectively. The bar graphs are means + SEM. N=5–6 rats/group. *P<0.05 compared to aCSF treated spSHR. (G, H): At 90 days of age, rats were euthanized, brains removed and processed for RT-PCR analyses of MCP-1 (G) and IL-1β (H) respectively. The bar graphs are means + SEM. N=5 rats/group.

    Journal: Experimental physiology

    Article Title: Centrally administered angiotensin-(1–7) increases the survival of stroke prone spontaneously hypertensive rats

    doi: 10.1113/expphysiol.2013.075242

    Figure Lengend Snippet: (A-F) Rats were fed a 4% sodium diet, infused ICV with either aCSF (0.15 μL/h) or Ang-(1–7) [1.0 μg in 0.15 μl aCSF/h]. (A-F): At 90 days of age rats were deeply anesthetized, perfused transcardially with saline followed by 10% formalin and brains removed for immunostaining as described in the Methods. Panels A and B are representative fluorescence micrographs showing Iba-1 immunoreactivity in the striatum of aCSF and Ang-(1–7) infused rats, respectively. Panels C and D are representative fluorescence micrographs showing NeuN immunoreactivity in the striatum of aCSF and Ang-(1–7) infused rats, respectively. LV= lateral ventricle; cc = Corpus callosum. Stereological analyses of the striatum showing the estimated numbers of Iba-1 positive cells (microglia) and NeuN positive cells (neurons) are shown in panels E and F respectively. The bar graphs are means + SEM. N=5–6 rats/group. *P<0.05 compared to aCSF treated spSHR. (G, H): At 90 days of age, rats were euthanized, brains removed and processed for RT-PCR analyses of MCP-1 (G) and IL-1β (H) respectively. The bar graphs are means + SEM. N=5 rats/group.

    Article Snippet: Rabbit anti-Ang-(1–7) Mas receptor antibody was from Alomone Labs (Jerusalem, Israel).

    Techniques: Immunostaining, Fluorescence, Reverse Transcription Polymerase Chain Reaction